David Ricks

David Ricks is the current CEO of Eli Lilly, a pharmaceutical company. He has been with the company since 2017 and has led the company's efforts to develop new treatments for various diseases, including Alzheimer's. Prior to joining Eli Lilly, Ricks worked at several other pharmaceutical companies, including Merck and Pfizer. He has a degree in pharmacy from the University of Michigan and has received several awards for his work in the pharmaceutical industry. Ricks is known for his leadership and his commitment to developing new treatments for patients with serious diseases.